...
首页> 外文期刊>World Journal of Surgical Oncology >Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression
【24h】

Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression

机译:基于手术后进展模式的佐剂放射治疗胃腺癌治疗的评估

获取原文

摘要

To assess the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma and to investigate subgroups of patients suitable for adjuvant radiotherapy. Data from 785 patients with gastric adenocarcinoma who had undergone D1/D2 radical resection and adjuvant chemotherapy were collected, the site of first progression was determined, and the relationship between the rate of local recurrence and clinicopathologic features was analyzed. By the end of the follow-up period, progression was observed in 405 patients. Local recurrence was observed as the first progression in 161 cases. The local recurrence rate was significantly lower than the non-local progression rate (20.5% vs 31.5%, p=0.007). Multivariate Cox regression analysis showed a significant relationship among degree of differentiation, T stage, N stage, and rate of local recurrence. Not all patients with gastric carcinoma required adjuvant radiotherapy. However, patients with poorly differentiated cancer cells, advanced T stage (T3/T4), and positive lymph nodes, which included patients in the T4N1-2M0 subgroup, were recommended for adjuvant radiotherapy.
机译:评估佐剂放射治疗胃腺癌治疗的价值,并研究适合佐剂放射治疗的患者的亚组。收集了785例胃腺癌患者的数据,确定了第一进展的部位,分析了局部复发和临床病理学率之间的关系。在随访期结束时,在405名患者中观察到进展。观察到局部复发作为161例的第一个进展。局部复发率明显低于非局部进展速率(20.5%vs 31.5%,p = 0.007)。多元COX回归分析显示出分化程度,T阶段,N阶段和局部复发率之间的显着关系。并非所有胃癌患者都需要佐剂放射疗法。然而,患有癌细胞差,癌细胞差,高级T阶段(T3 / T4)和阳性淋巴结患者推荐用于辅助放疗的T4N1-2M0亚组中的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号